GlassScriptPhysician profile
Angela Collins
NPI 1578960688
$1,634.63
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $631 · 2022: $456 · 2023: $457 · 2024: $91.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.65 | 2021-2024 | |
| Novo Nordisk INC | $198.85 | 2021-2023 | Wegovy |
| Janssen Pharmaceuticals, INC | $130.20 | 2021-2023 | Xarelto |
| Glaxosmithkline, LLC. | $106.59 | 2021-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $98.29 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $67.66 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $65.27 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $52.94 | 2021 | |
| Pfizer INC. | $51.96 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.98 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.14 | 2021-2022 | |
| Amgen INC. | $39.18 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.92 | 2021-2023 | Gardasil 9, M-M-R II, Vaxelis |
| Eisai INC. | $38.04 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.21 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $30.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.11 | 2022 | |
| Corium, LLC | $24.60 | 2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $19.47 | 2023 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $16.00 | 2021 | |
| Dynavax Technologies Corporation | $15.70 | 2022 | |
| Astellas Pharma US INC | $13.82 | 2022 | |
| Amarin Pharma, INC. | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.